Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

C230055K05Rik Activators

Zfp951, identified as a zinc finger protein, assumes a pivotal role in the intricate orchestration of gene expression by virtue of its predicted DNA-binding transcription factor activities, particularly those specific to RNA polymerase II cis-regulatory region sequences. This zinc finger protein is anticipated to play a significant part in the regulation of transcription by RNA polymerase II, reflecting its involvement in the complex and tightly regulated processes governing the synthesis of RNA molecules from DNA templates. The orthologous relationship with the human ZNF101 emphasizes the evolutionary conservation of this transcriptional regulator, suggesting a fundamental and conserved role across species. The activation of Zfp951 involves a sophisticated interplay of molecular events that influence its DNA-binding and transcriptional regulatory functions. The predicted activation mechanisms are intricately linked to the modulation of chromatin structure and the epigenetic landscape. Histone deacetylase (HDAC) inhibitors, such as Trichostatin A, SAHA (Vorinostat), and Sodium Butyrate, are poised to activate Zfp951 by impacting histone acetylation, altering the accessibility of the chromatin, and facilitating the transcriptional machinery's access to the target genes.

Furthermore, DNA methyltransferase inhibitors, exemplified by 5-Azacytidine, have the potential to activate Zfp951 by influencing the epigenetic marks on CpG islands, thereby participating in the regulation of gene expression. In addition to these epigenetic influencers, Zfp951 may be activated through the modulation of RNA polymerase II activity. Glucocorticoid receptor agonists like Dexamethasone may influence transcription and activate Zfp951 by modulating the activity of RNA polymerase II. BET bromodomain inhibitors, represented by JQ1 and I-BET151, disrupt BET protein function, impacting RNA polymerase II cis-regulatory region binding and potentially activating Zfp951. These various chemicals, by targeting distinct cellular processes and signaling pathways, collectively contribute to the nuanced activation of Zfp951, shedding light on the intricate regulatory mechanisms that govern transcriptional dynamics within the cell.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

HDAC inhibitor impacting histone acetylation, potentially activating Zfp951 by modulating chromatin structure and promoting transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA methyltransferase inhibitor demethylating CpG islands, potentially activating Zfp951 by influencing the epigenetic regulation of transcription.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Glucocorticoid receptor agonist influencing transcription, potentially activating Zfp951 through the modulation of RNA polymerase II activity.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

RNA polymerase inhibitor disrupting transcription, potentially activating Zfp951 by influencing RNA polymerase II activity.

6-Thioguanine

154-42-7sc-205587
sc-205587A
250 mg
500 mg
$42.00
$54.00
3
(1)

Purine analog impacting nucleotide synthesis, potentially activating Zfp951 by influencing RNA polymerase II-specific DNA binding activity.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

SIRT1 activator affecting histone deacetylation, potentially activating Zfp951 by modulating chromatin structure and promoting transcription.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

HDAC inhibitor impacting histone acetylation, potentially activating Zfp951 by altering chromatin structure and promoting transcription.

I-BET 151 Hydrochloride

1300031-49-5 (non HCl Salt)sc-391115
10 mg
$450.00
2
(0)

BET bromodomain inhibitor disrupting BET protein function, potentially activating Zfp951 by influencing RNA polymerase II cis-regulatory region binding.